Kelly L. Vallance

Hematology | Oncology

1500 Cooper St
Fort Worth, TX 76104

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Building a precision therapeutics program at a tertiary care children's hospital.

Building a precision therapeutics program at a tertiary care children's hospital.

Journal: Pediatric investigation

Published: February 09, 2026

Targeted Therapy in Pediatric Langerhans Cell Histiocytosis: Describing a Novel Strategy to Minimize Long-Term Exposure While Maintaining Efficacy.

Targeted Therapy in Pediatric Langerhans Cell Histiocytosis: Describing a Novel Strategy to Minimize Long-Term Exposure While Maintaining Efficacy.

Journal: Pediatric blood & cancer

Published: September 01, 2025

Updated favourable-histology Wilms tumour risk stratification: rationale for future Children's Oncology Group clinical trials.

Updated favourable-histology Wilms tumour risk stratification: rationale for future Children's Oncology Group clinical trials.

Journal: Nature reviews. Urology

Published: May 30, 2025

Associations of Patient Age, Tumor Nephrectomy Weight, and Tumor Diameter with Event-Free and Overall Survival in Stage I or II Favorable Histology Wilms Tumor: A Pooled Analysis of Children's Oncology Group Studies AREN0532 and AREN03B2.

Associations of Patient Age, Tumor Nephrectomy Weight, and Tumor Diameter with Event-Free and Overall Survival in Stage I or II Favorable Histology Wilms Tumor: A Pooled Analysis of Children's Oncology Group Studies AREN0532 and AREN03B2.

Journal: Annals of surgery

Published: April 11, 2025

Comparing the Diagnostic Yield of Germline Exome Versus Panel Sequencing in the Diverse Population of the Texas KidsCanSeq Pediatric Cancer Study.

Comparing the Diagnostic Yield of Germline Exome Versus Panel Sequencing in the Diverse Population of the Texas KidsCanSeq Pediatric Cancer Study.

Journal: JCO precision oncology

Published: September 11, 2024

Combined bioinformatic and splicing analysis of likely benign intronic and synonymous variants reveals evidence for pathogenicity.

Combined bioinformatic and splicing analysis of likely benign intronic and synonymous variants reveals evidence for pathogenicity.

Journal: Genetics in medicine open

Published: November 16, 2023

Combined Bioinformatic and Splicing Analysis of Likely Benign Intronic and Synonymous Variants Reveals Evidence for Pathogenicity.

Combined Bioinformatic and Splicing Analysis of Likely Benign Intronic and Synonymous Variants Reveals Evidence for Pathogenicity.

Journal: medRxiv : the preprint server for health sciences

Published: November 14, 2023

BRAF Exon 15 Mutations in the Evaluation of Well-Differentiated Epithelial Nephroblastic Neoplasms in Children: A Report From the Children's Oncology Group Study AREN03B2.

BRAF Exon 15 Mutations in the Evaluation of Well-Differentiated Epithelial Nephroblastic Neoplasms in Children: A Report From the Children's Oncology Group Study AREN03B2.

Journal: Archives of pathology & laboratory medicine

Published: September 29, 2023

Children's Oncology Group's 2023 blueprint for research: Renal tumors.

Children's Oncology Group's 2023 blueprint for research: Renal tumors.

Journal: Pediatric blood & cancer

Published: July 06, 2023

Prognostic impact of lymph node involvement and loss of heterozygosity of 1p or 16q in stage III favorable histology Wilms tumor: A report from Children's Oncology Group Studies AREN03B2 and AREN0532.

Prognostic impact of lymph node involvement and loss of heterozygosity of 1p or 16q in stage III favorable histology Wilms tumor: A report from Children's Oncology Group Studies AREN03B2 and AREN0532.

Journal: Cancer

Published: July 05, 2023

Circulating tumor DNA sequencing of pediatric solid and brain tumor patients: An institutional feasibility study.

Circulating tumor DNA sequencing of pediatric solid and brain tumor patients: An institutional feasibility study.

Journal: Pediatric hematology and oncology

Published: June 27, 2023

Families' experiences accessing care after genomic sequencing in the pediatric cancer context: "It's just been a big juggle".

Families' experiences accessing care after genomic sequencing in the pediatric cancer context: "It's just been a big juggle".

Journal: Journal of genetic counseling

Published: January 10, 2023

Showing 1-12 of 20

Last Updated: 09/26/2026